Join us at this year’s ISBT Congress
Explore our complete solution for blood management and pre-donation screening at booth #1625. As the innovators of Hb point-of-care testing, we’re excited to showcase our portfolio of products and answer any questions you may have.
The 33rd Regional Congress of ISBT will be held at Svenska Mässan (Swedish Congress and Convention Center) from June 17-21, 2023. The event covers a wide range of topics in Transfusion Medicine, including blood donation, management and organization, blood products and components, clinical transfusions, and quality management. The scientific program will also include workshops and special sessions.
We will be exhibiting from June 18-20 and look forward to seeing you in our booth #1625!
For further information on the congress please go to the ISBT Website.
Book a meeting with us:
Explore our Hb product portfolio
From blood collection to blood transfusion – meeting the need while protecting the source.
A challenge for blood donation facilities is often meeting the need for blood while protecting the donor. By using blood analysis methods that are accurate and precise, both goals can be met and guarantee the safety of the recipient. For efficient blood management, methods that provide fast answers are a necessity – when response time is critical, treatment decisions can’t wait for delayed hemoglobin results.
HemoCue provides total hemoglobin solutions, from blood collection to blood transfusion. Our hemoglobin systems are the trusted technologies for precision and lab accuracy around the world.
Read more about the HemoCue products covering blood banks here.
White blood cell count provides valuable information in the diagnosis or exclusion of an infection. Based on HemoCue’s microcuvette technology, the WBC system allows medical professionals to accurately determine total white blood cell counts right at the point of care.
The WHO called for reducing anemia by 50% in women of reproductive age, as part of its 2025 World Health Assembly Global Nutrition Targets. This made the assessment of anemia a global priority, and at HemoCue, we knew that we could make a difference. We launched 
